Skip to content
Companies

ThinkBio.Ai

Drug success scoring from a biomedical knowledge graph

Raised to date

No sales reported yet

of $20M offered across 1 Form D filing

Still open
$20M
Last filed
May 18, 2026

About

ThinkBio.Ai is an AI-first life sciences and healthcare software company that turns biomedical data into scientific and clinical intelligence. Its platforms sit on a proprietary biological knowledge graph spanning more than 250 million biological relationships, and cover drug discovery scoring, clinical trial design, and longitudinal patient views. Founded in 2024 and headquartered in Ontario, California, it also operates in the UK and India, and in 2025 acquired Kerala-based Feathersoft InfoSolutions to expand its platform engineering capacity. Customers are global biopharma, biotech and healthcare organizations working on drug discovery and precision medicine.

Federates multi-omics, clinical and real-world data into a single biological knowledge graph, then exposes it through explainable AI products that span the full path from target discovery through trial design to point-of-care decisions, rather than addressing one stage in isolation.

Funding

  • EquityFiled May 18, 2026Form D
    None sold/ $20M

Product

DrugSuccess.Ai

Drug discovery software

A discovery intelligence platform that produces a Drug Success Score for therapeutic candidates by reasoning over multi-omics data and a knowledge graph of more than 250 million biological relationships.

  • Drug Success Score for candidate prioritization
  • Multi-omics data integration
  • Knowledge graph of 250M+ biological relationships

Built for

Global biopharma and biotech companies, clinical research organizations, and healthcare systems practicing precision medicine

People on file